< Back to all Breaking News
AVIR
5/26/2016 16:05pm
Aviragen delays enrollment in Phase 2a trial of BTA585
Don't miss out!
We read the Wall Street research, SEC filings and press releases so you don't have to.
Sign up for our 14-day free trial to read this story.